课题基金 / 基金详情

Genomic risk in clinic care to promote health equity in New York City patients

Genomic risk in clinic care to promote health equity in New York City patients
临床护理中的基因组风险促进纽约市患者的健康公平
批准号:
10850453
负责人:
NOURA SERENE ABUL-HUSN
金额:
$14.97万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-07-01 至 2025-04-30

项目摘要

项目成果

NOURA SERENE ABUL-HUSN的其他基金

相似基金

相关文献

中文摘要
翻译
整合临床病史、家庭因素的疾病风险预测
英文摘要
PROJECT SUMMARY / ABSTRACT Disease risk prediction that integrates aspects of clinical history, family history, and lifestyle factors is a core tenet of preventive medicine, with genomic risk increasingly being recognized as a component that may enhance the prediction of disease. In addition to strong risk factors in single genes (monogenic risk), polygenic risk scores (PRS) combine the many small effects of variants across the genome to estimate an individual's disease risk. While PRS are poised to enhance risk prediction for common disease, current challenges to clinical implementation include lack of validation in non-European ancestry groups, and barriers to access to leading-edge genomic technology, research, and testing among underserved populations. The eMERGE 4 Network is conducting a study to prospectively enroll 25,000 adults and children across 10 clinical sites in the United States and return an integrated risk report, called the Genome Informed Risk Assessment (GIRA), which incorporates PRS for 10 common conditions with family history, monogenic risk, social and clinical determinants. Using the GIRA to identify individuals at high risk, the Network will assess uptake of preventive health measures and health outcomes. The Mount Sinai Health System (MS) has been selected as an eMERGE 4 enhanced diversity clinical site, where we have recruited 1,520 of our target 2,500 participants, >75% of whom are from medically underserved populations. At the midpoint of the project, in response to some delays in Network recruitment, we have been asked to recruit an additional 175 adult participants beyond our original goal of 2,500. The Specific Aim for this supplement is to expand enrollment of adult participants from diverse communities in New York City. We will accomplish this by 1) continuing targeted outreach, 2) maintaining a presence in primary care clinics across Mount Sinai, 3) engaging physician champions, clinic staff, and practice managers, 4) bringing on additional recruitment sites as needed, 5) extending recruitment through end July 2024, and 6) continuing outreach and engagement efforts to participants and providers. We will extract data on health outcomes from electronic health records, and other data as requested. Upon completion of this aim we will deliver completed surveys, family histories, meta data, and EHR-derived health outcome data for an additional 175 diverse adults from the Mount Sinai Health System to contribute to the research goals of the eMERGE 4 Network, and will work within the eMERGE Network working groups to analyze these data.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s10689-021-00257-x
发表时间: 2022-04
期刊: Familial cancer
影响因子: 2.2
作者: [Bar-Mashiah A, Soper ER, Cullina S, Belbin GM, Kenny EE, Lucas AL, Abul-Husn NS]
通讯作者: Abul-Husn NS
DOI: 10.1200/po.20.00290
发表时间: 2020-01-01
期刊: JCO precision oncology
影响因子: 4.6
作者: [Rosenblum, Rachel E, Ang, Celina, Abul-Husn, Noura S]
通讯作者: Abul-Husn, Noura S
DOI: 10.1016/j.gim.2022.03.006
发表时间: 2022-06
期刊: GENETICS IN MEDICINE
影响因子: 8.8
作者: [Suckiel, Sabrina A., Braganza, Giovanna T., Aguiniga, Karla Lopez, Odgis, Jacqueline A., Bonini, Katherine E., Kenny, Eimear E., Hamilton, Jada G., Abul-Husn, Noura S.]
通讯作者: Abul-Husn, Noura S.
Genomic risk in clinic care to promote health equity in New York City patients
Genomic risk in clinic care to promote health equity in New York City patients
Genomic risk in clinic care to promote health equity in New York City patients
海外基金